Aqua-Spark backs new tech­nol­ogy

Fish Farmer - - News -

AQUA­CUL­TURE in­vestor Aqua-Spark an­nounced back­ing for two cut­ting edge tech­nol­ogy com­pa­nies that aim to make fish farm­ing health­ier and more ef­fi­cient by elim­i­nat­ing an­tibi­otics, re­duc­ing feed, and en­abling farms to safe­guard their brood­stock.

Pro­teon is trans­form­ing bac­te­rio­phages, or ‘phages’, found in na­ture into com­mer­cial grade prod­ucts that tar­get bac­te­rial in­fec­tions in a way that doesn’t cre­ate re­sis­tance.

The com­pany has two main prod­ucts on the mar­ket: a so­lu­tion against pseu­domonas and aeromonas in­fec­tions in fish and a so­lu­tion against sal­mo­nella in­fec­tions in poul­try.

Mean­while, another com­pany, Cry­oocyte, has de­vel­oped high-pre­ci­sion fish farm­ing tech­nol­ogy to bring greater con­trol and ac­cu­racy to fish breed­ing.

Through tech­nol­ogy for low tem­per­a­ture preser­va­tion of un­fer­tilised eggs, Cry­oocyte al­lows more time to as­sess ge­netic ma­te­rial be­fore mat­ing de­ci­sions must be made.

New data on egg qual­ity, pres­ence of dis­ease, and parental DNA helps Cry­oocyte’s cus­tomers make more pre­cise male-fe­male mat­ing de­ci­sions and pro­duce nat­u­rally health­ier off­spring.

With th­ese in­vest­ments, Aqua-Spark said it has en­tered new ar­eas of the value chain where there is po­ten­tial to dra­mat­i­cally im­prove the in­dus­try over­all.

Above: Cry­oocyte has at­tracted und­ing

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.